FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/07/035104 [Registered on: 26/07/2021] Trial Registered Prospectively
Last Modified On: 14/02/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Vaccine 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A STUDY ON ANALGESIC EFFECTS DURING VACCINATION IN HEALTHY TERM INFANTS  
Scientific Title of Study   A STUDY ON THE ANALGESIC EFFECTS OF DIRECT BREASTFEEDING AND 24 %SUCROSE SOLUTION AGAINST A CONTROL GROUP DURING VACCINATION IN HEALTHY TERM INFANTS  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR AKHILA KURIAN  
Designation  Postgraduate student  
Affiliation  MALANKARA ORTHODOX SYRIAN CHURCH MEDICAL COLLEGE  
Address  DEPARTMENT OF PAEDIATRICS MOSC MEDICAL COLLEGE KOLENCHERY

Ernakulam
KERALA
682311
India 
Phone  9400632516   
Fax    
Email  drakhilakurian@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR ISAC MATHAI 
Designation  Head of department  
Affiliation  MALANKARA ORTHODOX SYRIAN CHURCH MEDICAL COLLEGE  
Address  Department of paediatrics MOSC MEDICAL COLLEGE KOLENCHERY

Ernakulam
KERALA
682311
India 
Phone  9447036732  
Fax    
Email  drisacmathai2016@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR AKHILA KURIAN  
Designation  POSTGRADUATE STUDENT  
Affiliation  MALANKARA ORTHODOX SYRIAN CHURCH MEDICAL COLLEGE  
Address  DEPARTMENT OF PAEDIATRICS MOSC MEDICAL COLLEGE KOLENCHERY

Ernakulam
KERALA
682311
India 
Phone  9400632516   
Fax    
Email  drakhilakurian@gmail.com  
 
Source of Monetary or Material Support  
MALANKARA ORTHODOX SYRIAN CHURCH MEDICAL COLLEGE  
 
Primary Sponsor  
Name  DR AKHILA KURIAN  
Address  DEPARTMENT OF PAEDIATRICS MOSC MEDICAL COLLEGE KOLENCHERY  
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR AKHILA KURIAN   MALANKARA ORTHODOX SYRIAN CHURCH MEDICAL COLLEGE   DEPARTMENT OF PAEDIATRICS KOLENCHERY PINCODE - 682311
Ernakulam
KERALA 
9400632516

drakhilakurian@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
MALANKARA ORTHODOX SYRIAN CHURCH MEDICAL COLLEGE INSTITUTIONAL ETHICS COMMITTEE   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Healthy term infants coming to Paediatric OPD for infantrix Hexa vaccination at 6 weeks  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  24%sucrose solution administration   In one of the three randomised groups, 24%sucrose solution is administered 2minutes prior to vaccination. This intervention is done only in one randomised group.  
Comparator Agent  Infantrix Hexa   Randomising infants coming for infantrix Hexa vaccination into three groups. One group is control, the other is breast feed 1 hour prior to procedure and third is given 24%sucrose solution  
 
Inclusion Criteria  
Age From  45.00 Day(s)
Age To  1.00 Year(s)
Gender  Both 
Details 
Term infants, who are exclusively or partially breastfed and attending the immunization clinic for infantrix Hexa(GSK) vaccination under 1 year of age (6weeks ) .
Healthy, developmentally appropriate infants born at 37to 42 weeks’ gestation, with birth weight
≥2.5 kg,
All infants should have been fed within three hours prior to the intervention, but shouldn’t have had a feed in the past 30 minutes.  
 
ExclusionCriteria 
Details  EXCLUSION CRITERIA: Infants with a current illness
-unable to tolerate fluids by mouth
- with cerebral palsy where response to painful stimuli may be altered
-with perinatal asphyxia with congenital malformations and developmental delay 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment    
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
The primary outcome variable- acute behavioural pain response, will be assessed using a composite score obtained from the modified behavioural pain score for infants.

 
2 years

 
 
Secondary Outcome  
Outcome  TimePoints 
Duration of cry ,latency of onset(from administration to onset of cry) - Heart rate measurement prior(5min) and post administration at 5 minutes - SpO2 monitoring will also be done at 5 minutes before and after  10min 
 
Target Sample Size   Total Sample Size="141"
Sample Size from India="141" 
Final Enrollment numbers achieved (Total)= "149"
Final Enrollment numbers achieved (India)="149" 
Phase of Trial   N/A 
Date of First Enrollment (India)   26/07/2021 
Date of Study Completion (India) 01/02/2022 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   Not yet published  
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a randomized control trial of healthy Infants under 1 year of age coming for vaccination to paediatric OPD of MALANKARA ORTHODOX SYRIAN CHURCH MEDICAL COLLEGE   Children are randomised into 3 groups using computer generated block randomisation . Analgesic effect of 24%sucrose and breast feeding against a control group is assessed during vaccination. Pain is evaluated using modified behavioural pain scale (MBPS) Along with heart rate, Saturation monitoring as a secondary outcome   Each group a sample size of 47 is expected  So, total sample size of 141 together in all 3 groups  
Close